Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SKP1P3 is a pseudogene of the S-phase kinase-associated protein 1 (SKP1) gene, meaning it is a non-coding genomic sequence homologous to SKP1 but does not produce a functional protein product. The canonical SKP1 protein is an essential adaptor subunit of the SCF (Skp1-Cullin-F-box) E3 ubiquitin ligase complex, which has a critical role in protein ubiquitination and cell cycle regulation[1][2]. However, SKP1P3 itself is not a protein-coding gene, does not produce a functional protein, and is not considered a therapeutic target, enzyme, receptor, or otherwise druggable target. There are currently no known biological functions, disease associations, or drugs interacting specifically with SKP1P3. The name may introduce confusion due to its similarity to the functional SKP1 gene and protein, which are extensively studied in oncology, cell cycle control, and targeted protein degradation, but SKP1P3 is not itself a proper drug target or functional molecule[1][2]. If your intention was to inquire about the actual functional molecule, refer to S-phase kinase-associated protein 1 (SKP1), not the pseudogene SKP1P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on S-phase kinase associated protein 1 pseudogene 3 (SKP1P3).